Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic
- 1 June 2020
- journal article
- letter
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 82 (6) , e207-e209
Abstract
No abstract availableKeywords
Funding Information
- Sanofi Genzyme
- Regeneron
- AbbVie
- Eli Lilly
- Novartis
- Sun Pharma
- LEO Pharma
- Pfizer
- Menlo Therapeutics
- Burt’s Bees
- GpSkin
- Altus Labs
- Skin Actives Scientific
- Amgen
- Bristol-Myers Squibb
- Helsinn
- Novartis
This publication has 3 references indexed in Scilit:
- Virtually Perfect? Telemedicine for Covid-19New England Journal of Medicine, 2020
- What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?Journal of the American Academy of Dermatology, 2020
- Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)Journal of Telemedicine and Telecare, 2020